These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Inhibition by estramustine phosphate on estradiol and androgen binding in benign and malignant prostate in humans. Author: Nilsson I, Liskowski L, Nilsson T. Journal: Urology; 1976 Aug; 8(2):118-21. PubMed ID: 60819. Abstract: Specific cytoplasmic androgen and estrogen binding has been measured in human benign prostatic hypertrophy and carcinomatous tissue. In vitro support for the binding of estramustine phosphate (Estracyt) to both estradiol- and dihydrotestosterone-binding sites is presented, which in part could explain the clinical effect of estramustine phosphate when pure estrogenic compunds are not effective.[Abstract] [Full Text] [Related] [New Search]